Colonic Neoplasms × Plasma cell × 90 days × Clear all
NCT02465060 2026-04-13

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
6,452 enrolled 2 FDA
NCT02012699 2026-01-22

iCaRe2

University of Nebraska

Recruiting
999,999 enrolled